Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The molecular perspective: the ras oncogene.

Literature DB >> 10394594

The molecular perspective: the ras oncogene.

D S Goodsell¹.

Abstract

Mesh：

Substances：
DNA

Year: 1999 PMID： 10394594

Source DB: PubMed Journal: Oncologist ISSN： 1083-7159

Keyword Cloud
Cited

× No keyword cloud information.

37 in total

Review 1. Spatial cycles in G-protein crowd control.

Authors: Nachiket Vartak; Philippe Bastiaens
Journal: EMBO J Date: 2010-08-18 Impact factor: 11.598

Review 2. Pancreatic cancer, treatment options, and GI-4000.

Authors: Marion L Hartley; Najeebah A Bade; Petra A Prins; Leonel Ampie; John L Marshall
Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452

3. Micro RNA responses to chronic or acute exposures to low dose ionizing radiation.

Authors: M Ahmad Chaudhry; Romaica A Omaruddin; Bridget Kreger; Sonia M de Toledo; Edouard I Azzam
Journal: Mol Biol Rep Date: 2012-02-25 Impact factor: 2.316

Review 4. Pancreatic cancer, treatment options, and GI-4000.

Authors: Marion L Hartley; Najeebah A Bade; Petra A Prins; Leonel Ampie; John L Marshall
Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452

5. Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?

Authors: Omar Abdel-Rahman
Journal: J Thorac Dis Date: 2016-08 Impact factor: 2.895

6. Probing the wild-type HRas activation mechanism using steered molecular dynamics, understanding the energy barrier and role of water in the activation.

Authors: Neeru Sharma; Uddhavesh Sonavane; Rajendra Joshi
Journal: Eur Biophys J Date: 2014-01-20 Impact factor: 1.733

The molecular perspective: the ras oncogene.

Review 1. Spatial cycles in G-protein crowd control.

Review 2. Pancreatic cancer, treatment options, and GI-4000.

3. Micro RNA responses to chronic or acute exposures to low dose ionizing radiation.

Review 4. Pancreatic cancer, treatment options, and GI-4000.

5. Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?

6. Probing the wild-type HRas activation mechanism using steered molecular dynamics, understanding the energy barrier and role of water in the activation.

7. Synthesis of novel Ral inhibitors: An in vitro and in vivo study.

Review 8. Values of molecular markers in the differential diagnosis of thyroid abnormalities.

9. Methylation pattern of oncogene HRAS gene promoter region and its clinical relevance to urocystic tumorigenesis.

10. A sequence-based hybrid predictor for identifying conformationally ambivalent regions in proteins.